[1] YUN S H, KWOK S J J. Light in diagnosis, therapy and surgery［J］. Nature Biomedical Engineering, 2017, 1(1): 0008.

[2] 李步洪, 谢树森. 功能型光敏剂的研究进展［J］. 中国激光医学杂志, 2007, 16(3): 179-185.

    LI Buhong, XIE Shusen. Functional photosensitizers for photodynamic therapy:recent developments［J］. Chinese Journal of Laser Medicine and Surgery, 2007, 16(3): 179-185.

[3] ZHANG H, LI Y H, CHEN Y, et al. Fluorescence and magnetic resonance dual-modality imaging-guided photothermal and photodynamic dual-therapy with magnetic porphyrin-metal organic framework nanocomposites［J］. Scientific Reports, 2017, 7: 44153.

[4] MEHRABAN N, FREEMAN H S. Developments in PDT sensitizers for increased selectivity and singlet oxygen production［J］. Materials, 2015, 8(7): 4421-4456.

[5] LI P X, MU J H, XIAO H L, et al. Antitumor effect of photodynamic therapy with a novel targeted photosensitizer on cervical carcinoma［J］. Oncology Reports, 2015, 33(1): 125-132.

[6] FAN W, HUANG P, CHEN X. Overcoming the achilles’ heel of photodynamic therapy［J］. Chemical Society Reviews, 2016, 45(23): 6488-6519.

[7] RAPOZZI V, DELLA PIETRA E, BONAVIDA B. Dual roles of nitric oxide in the regulation of tumor cell response and resistance to photodynamic therapy［J］. Redox Biology, 2015, 6: 311-317.

[8] LUCKY S S, SOO K C, ZHANG Y. Nanoparticles in photodynamic therapy［J］. Chemical Reviews, 2015, 115(4): 1990-2042.

[9] WIEGELL S R, WULF H C, SZEIMIES R M, et al. Daylight photodynamic therapy for actinic keratosis:an international consensus［J］. Journal of the European Academy of Dermatology and Venereology, 2012, 26(6): 673-679.

[10] SOTIRIOU E, EVAGELOU G, PAPADAVID E, et al. Conventional vs.daylight photodynamic therapy for patients with actinic keratosis on face and scalp:12-month follow-up results of a randomized, intraindividual comparative analysis［J］. Journal of the European Academy of Dermatology and Venereology, 2018, 32(4): 595-600.

[11] CORDEY H, VALENTINE R, LESAR A, et al. Daylight photodynamic therapy in Scotland［J］. Scottish Medical Journal, 2017, 62(2): 48-53.

[12] WIEGELL S R, FABRICIUS S, GNIADECKA M, et al. Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp:a randomized multicentre study［J］. British Journal of Dermatology, 2012, 166(6): 1327-1332.

[13] O’MAHONEY P, KHAZOVA M, HIGLETT M, et al. Use of illuminance as a guide to effective light delivery during daylight photodynamic therapy in the UK［J］. British Journal of Dermatology, 2017, 176(6): 1607-1616.

[14] MA Z, JI H, TAN D, et al. Porous YAG∶Nd3+ fibers with excitation and emission in the human “NIR optical window” as luminescent drug carriers［J］. Chemistry-A European Journal, 2012, 18(9): 2609-2616.

[15] WANG D, LIU B, QUAN Z, et al. New advances on the marrying of UCNPs and photothermal agents for imaging-guided diagnosis and the therapy of tumors［J］. Journal of Materials Chemistry B, 2017, 5(12): 2209-2230.

[16] VANKAYALA R, HUANG Y K, KALLURU P, et al. First demonstration of gold nanorods-mediated photodynamic therapeutic destruction of tumors via near infrared light activation［J］. Small, 2014, 10(8): 1612-1622.

[17] KIM T I, JEONG K H, MIN K S. Verrucous epidermal nevus (VEN)successfully treated with indocyanine green (ICG)photodynamic therapy (PDT)［J］. JAAD Case Reports, 2015, 1(5): 312-314.

[18] BOREHAM E M, JONES L, SWINBURNE A N, et al. A cyclometallated fluorenyl Ir (iii)complex as a potential sensitiser for two-photon excited photodynamic therapy (2PE-PDT)［J］. Dalton Transactions, 2015, 44(36): 16127-16135.

[19] KAROTKI A, KHURANA M, LEPOCK J R, et al. Simultaneous two-photon excitation of photofrin in relation to photodynamic therapy［J］. Photochemistry and Photobiology, 2006, 82(2): 443-452.

[20] SUN Z, ZHANG L P, WU F, et al. Photosensitizers for two-photon excited photodynamic therapy［J］. Advanced Functional Materials, 2017, 27(48): 1704079.

[21] COLLINS H A, KHURANA M, MORIYAMA E H, et al. Blood-vessel closure using photosensitizers engineered for two-photon excitation［J］. Nature Photonics, 2008, 2(7): 420-424.

[22] GUO L, GE J, LIU Q, et al. Versatile polymer nanoparticles as two-photon-triggered photosensitizers for simultaneous cellular, deep-tissue imaging, and photodynamic therapy［J］. Advanced Healthcare Materials, 2017, 6(12): 1601431.

[23] BLAZQUEZCASTRO A. Direct 1O2 optical excitation:a tool for redox biology［J］. Redox Biology, 2017, 13: 39-59.

[24] ANQUEZ F, ELYAZIDI-BELKOURA I, RANDOUX S, et al. Cancerous cell death from sensitizer free photoactivation of singlet oxygen［J］. Photochemistry and Photobiology, 2012, 88(1): 167-174.

[25] GENING T P, VORONOVA O S, DOLGOVA D R, et al. Analysis of the efficiency of using 1265-nm CW laser radiation for initiating oxidative stress in the tissue of a solid malignant tumour［J］. Quantum Electron, 2012, 42(9): 805-807.

[26] SOKOLOVSKI S G, ZOLOTOVSKAYA S A, GOLTSOV A, et al. Infrared laser pulse triggers increased singlet oxygen production in tumour cells［J］. Scientific Reports, 2013, 3: 3484.

[27] SAENKO Y V, GLUSHCHENKO E S, ZOLOTOVSKII L O, et al. Mitochondrial dependent oxidative stress in cell culture induced by laser radiation at 1265 nm［J］. Lasers in Medical Science, 2016, 31(3): 405-413.

[28] LI Z, ZHANG Y, HAN G. Lanthanide-doped upconversion nanoparticles for imaging-guided drug delivery and therapy［M］. Berlin Heidelberg : Springer Verlag, 2016: 139-164.

[29] CHEN G, SONG F, XIONG X, et al. Fluorescent nanosensors based on fluorescence resonance energy transfer［J］. Industrial & Engineering Chemistry Research, 2013, 52(33): 11228-11245.

[30] WANG C, TAO H, CHENG L, et al. Near-infrared light induced in vivo photodynamic therapy of cancer based on upconversion nanoparticles［J］. Biomaterials, 2011, 32(26): 6145-6154.

[31] CUI S, YIN D, CHEN Y, et al. In vivo targeted deep-tissue photodynamic therapy based on near-infrared light triggered upconversion nanoconstruct［J］. American Chemical Society Nano, 2013, 7(1): 676-688.

[32] IDRIS N M, GNANASAMMANDHAN M K, ZHANG J, et al. In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers［J］. Nature Medicine, 2012, 18(10): 1580-1585.

[33] PUNJABI A, WU X, TOKATLIAPOLLON A, et al. Amplifying the red-emission of upconverting nanoparticles for biocompatible clinically used prodrug-induced photodynamic therapy［J］. American Chemical Society Nano, 2014, 8(10): 10621-10630.

[34] WANG H, ZHU X, HAN R, et al. Near-infrared light activated photodynamic therapy of THP-1 macrophages based on core-shell structured upconversion nanoparticles［J］. Microporous and Mesoporous Materials, 2017, 239: 78-85.

[35] HU J, TANG Y A, ELMENOUFY A H, et al. Nanocomposite-based photodynamic therapy strategies for deep tumor treatment［J］. Small, 2015, 11(44): 5860-5887.

[36] WANG G D, NGUYEN H T, CHEN H, et al. X-ray induced photodynamic therapy:a combination of radiotherapy and photodynamic therapy［J］. Theranostics, 2016, 6(13): 2295-2305.

[37] CLEMENT S, DENG W, CAMILLERI E, et al. X-ray induced singlet oxygen generation by nanoparticle-photosensitizer conjugates for photodynamic therapy:determination of singlet oxygen quantum yield［J］. Scientific Reports, 2016, 6: 19954.

[38] CHEN W, ZHANG J. Using nanoparticles to enable simultaneous radiation and photodynamic therapies for cancer treatment［J］. Journal of Nanoscience & Nanotechnology, 2006, 6(4): 1159-1166.

[39] COLLINS J E, KUMAR A, WAYNANT R W, et al. Novel applications of diagnostic X-rays in activating photo-agents through X-ray induced visible luminescence from rare-earth particles:an in vitro study［J］. Proceedings of SPIE, 2010, 7565: 75650B.

[40] MA L, ZOU X J, CHEN W. A new X-ray activated nanoparticle photosensitizer for cancer treatment［J］. Journal of Biomedical Nanotechnology, 2014, 10(8): 1501-1508.

[41] TANG Y, HU J, ELMENOUFY A H, et al. Highly efficient fret system capable of deep photodynamic therapy established on X-ray excited mesoporous LaF3∶Tb scintillating nanoparticles［J］. American Chemical Society Applied Materials & Interfaces, 2016, 7(22): 12261-12269.

[42] YANG C C, SUN Y J, CHUNG P H, et al. Development of Ce-doped TiO2 activated by X-ray irradiation for alternative cancer treatment［J］. Ceramics International, 2017, 43(15): 12675-12683.

[43] MAGALHAES M C, ESTEVES DA SILVA J C G, DA SILVA L P. Chemiluminescence and bioluminescence as an excitation source in the photodynamic therapy of cancer:a critical review［J］. Chemphyschem, 2016, 17(15): 2286-2294.

[44] SO M K, LOENING A M, GAMBHIR S S, et al. Creating self-illuminating quantum dot conjugates［J］. Nature Protocols, 2006, 1(3): 1160-1164.

[45] HSU C Y, CHEN C W, YU H P, et al. Bioluminescence resonance energy transfer using luciferase-immobilized quantum dots for self-illuminated photodynamic therapy［J］. Biomaterials, 2013, 34(4): 1204-1212.

[46] KIM S, JO H C, JEON M, et al. Luciferase-rose bengal conjugates for singlet oxygen generation by bioluminescence resonance energy transfer［J］. Chemical Communications, 2017, 53(33): 4569-4572.

[47] LAPTEV R, NISNEVITCH M, SIBONI G, et al. Intracellular chemiluminescence activates targeted photodynamic destruction of leukaemic cells［J］. British Journal of Cancer, 2006, 95(2): 189-196.

[48] ZHANG Y, PANG L, MA C, et al. Small molecule-initiated light-activated semiconducting polymer dots:an integrated nanoplatform for targeted photodynamic therapy and imaging of cancer cells［J］. Analytical Chemistry, 2014, 86(6): 3092-3099.

[49] SINGH S V B, KIM J, PARK H, et al. Novel chemi-dynamic nanoparticles as a light-free photodynamic therapeutic system for cancer treatment［J］. Macromolecular Research, 2017, 25(7): 749-755.

[50] SPINELLI A E, BOSCHI F. Novel biomedical applications of cerenkov radiation and radioluminescence imaging［J］. Physica Medica-European Journal of Medical Physics, 2015, 31(2): 120-129.

[51] RAN C, ZHANG Z, HOOKER J, et al. In vivo photoactivation without “light”:use of cherenkov radiation to overcome the penetration limit of light［J］. Molecular Imaging & Biology, 2012, 14(2): 156-162.

[52] KOTAGIRI N, AKERS W J, ACHILEFU S, et al. Breaking the depth dependency of phototherapy with cerenkov radiation and low radiance responsive nanophotosensitizers［J］. Nature Nanotechnology, 2015, 10(4): 370-379.

[53] HARTL B A, HIRSCHBERG H, MARCU L, et al. Activating photodynamic therapy in vitro with cerenkov radiation generated from yttrium-90［J］. Journal of Environmental Pathology Toxicology and Oncology, 2016, 35(2): 185-192.

[54] KAMKAEW A, CHENG L, GOEL S, et al. Cerenkov radiation induced photodynamic therapy using chlorin e6-loaded hollow mesoporous silica nanoparticles［J］. Applied Materials & Interfaces, 2016, 8(40): 26630-26637.

[55] ERKIERTPOLGUJ A, HALBINA A, POLAKPACHOLCZYK I, et al. Light emitting diodes in photodynamic therapy in non-melanoma skin cancers - own observations and literature review［J］. Journal of Cosmetic & Laser Therapy, 2016, 18(2): 105-110.

[56] MOSELEY H, ALLEN J W, IBBOTSON S, et al. Ambulatory photodynamic therapy:a new concept in delivering photodynamic therapy［J］. British Journal of Dermatology, 2006, 154(4): 747-750.

[57] CHEN D F, ZHENG H F, HUANG Z Y, et al. Light-emitting diode-based illumination system for in vitro photodynamic therapy［J］. International Journal of Photoenergy, 2012, 2012: 920671.

[58] COCHRANE C, MORDON S R, LESAGE J C, et al. New design of textile light diffusers for photodynamic therapy［J］. Materials Science and Engineering C-Materials for Biological Applications, 2013, 33(3): 1170-1175.

[59] ATTILI S K, LESAR A, MCNEILL A, et al. An open pilot study of ambulatory photodynamic therapy using a wearable low-irradiance organic light-emitting diode light source in the treatment of nonmelanoma skin cancer［J］. British Journal of Dermatology, 2009, 161(1): 170-173.

[60] GRIFFIN L L, LEAR J T. Photodynamic therapy and non-melanoma skin cancer［J］. Cancers, 2016, 8(10): 170-173.

[61] MORDON S, COCHRANE C, TYLCZ J B, et al. Light emitting fabric technologies for photodynamic therapy［J］. Photodiagnosis and Photodynamic Therapy, 2015, 12(1): 1-8.

[62] KONCAR V. Optical fiber fabric displays［J］. Optics and Photonics News, 2005, 16(4): 40-44.

[63] SELM B, ROTHMAIER B, CAMENZIND M, et al. Novel flexible light diffuser and irradiation properties for photodynamic therapy［J］. Journal of Biomedical Optics, 2007, 12(3): 034024.

[64] HU Y, WANG K, ZHU T C. Pre-clinic study of uniformity of light blanket for intraoperative photodynamic therapy［J］. Proceedings of SPIE, 2010, 7551: 755112.

[65] HU X M, ZHANG F J, DONG F, et al. Three-dimensional illumination procedure for photodynamic therapy of dermatology［J］. Journal of Biomedical Optics, 2014, 19(9): 098003.

[66] ZHANG F J, HU X M, ZHOU Y, et al. Optimization of irradiance for photodynamic therapy of port-wine stain［J］. Journal of Biomedical Optics, 2015, 20(4): 048004.

[67] SHAFIRSTEIN G, BELLNIER D, OAKLEY E, et al. Interstitial photodynamic therapy-a focused review［J］. Cancers, 2017, 9(2): E12.

[68] JERJES W, UPILE T, HAMDOON Z, et al. Photodynamic therapy:the minimally invasive surgical intervention for advanced and/or recurrent tongue base carcinoma［J］. Lasers in Surgery & Medicine, 2011, 43(4): 283-292.

[69] KARAKULLUKCU B, NYST H J, VAN VEEN R L, et al. mTHPC mediated interstitial photodynamic therapy of recurrent nonmetastatic base of tongue cancers:development of a new method［J］. Head & Neck, 2012, 34(11): 1597-1606.

[70] JOHANSSON A, FABER F, KNIEBUEHLER G, et al. Protoporphyrin IX fluorescence and photobleaching during interstitial photodynamic therapy of malignant gliomas for early treatment prognosis［J］. Lasers in Surgery & Medicine, 2013, 45(4): 225-234.

[71] CANAVESI C, CASSARLY W J, FOSTER T H, et al. Lightpipe device for delivery of uniform illumination for photodynamic therapy of the oral cavity［J］. Applied Optics, 2011, 50(16): 2322-2325.

[72] MIYAZAKI K, MORIMOTO Y, NISHIYAMA N, et al. A novel homogeneous irradiation fiber probe for whole bladder wall photodynamic therapy［J］. Lasers in Surgery and Medicine, 2012, 44(5): 413-420.

[73] ZHU T C, KIM M M, ONG Y H, et al. A summary of light dose distribution using an IR navigation system for photofrin-mediated pleural PDT［J］. Proceedings of SPIE, 2017, 10047: 1004709.